Algernon Pharmaceuticals' market value is the price at which a share of Algernon Pharmaceuticals trades on a public exchange. It measures the collective expectations of Algernon Pharmaceuticals investors about its performance. Algernon Pharmaceuticals is trading at 0.0575 as of the 2nd of February 2025. This is a 6.81 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.0575. With this module, you can estimate the performance of a buy and hold strategy of Algernon Pharmaceuticals and determine expected loss or profit from investing in Algernon Pharmaceuticals over a given investment horizon. Check out Algernon Pharmaceuticals Correlation, Algernon Pharmaceuticals Volatility and Algernon Pharmaceuticals Alpha and Beta module to complement your research on Algernon Pharmaceuticals.
Please note, there is a significant difference between Algernon Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Algernon Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Algernon Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Algernon Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Algernon Pharmaceuticals' otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Algernon Pharmaceuticals.
0.00
01/03/2025
No Change 0.00
0.0
In 30 days
02/02/2025
0.00
If you would invest 0.00 in Algernon Pharmaceuticals on January 3, 2025 and sell it all today you would earn a total of 0.00 from holding Algernon Pharmaceuticals or generate 0.0% return on investment in Algernon Pharmaceuticals over 30 days. Algernon Pharmaceuticals is related to or competes with Cellectis, Covalon Technologies, Ascletis Pharma, GH Research, and Mosaic Immunoengineerin. Algernon Pharmaceuticals Inc. operates as a clinical stage pharmaceutical development company More
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Algernon Pharmaceuticals' otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Algernon Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for Algernon Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Algernon Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Algernon Pharmaceuticals historical prices to predict the future Algernon Pharmaceuticals' volatility.
Algernon Pharmaceuticals appears to be out of control, given 3 months investment horizon. Algernon Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.0345, which signifies that the company had a 0.0345 % return per unit of standard deviation over the last 3 months. We have found twenty-seven technical indicators for Algernon Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please makes use of Algernon Pharmaceuticals' risk adjusted performance of 0.0504, and Mean Deviation of 5.77 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Algernon Pharmaceuticals holds a performance score of 2. The firm shows a Beta (market volatility) of 1.22, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Algernon Pharmaceuticals will likely underperform. Please check Algernon Pharmaceuticals' information ratio, downside variance, day typical price, as well as the relationship between the treynor ratio and kurtosis , to make a quick decision on whether Algernon Pharmaceuticals' price patterns will revert.
Auto-correlation
0.05
Virtually no predictability
Algernon Pharmaceuticals has virtually no predictability. Overlapping area represents the amount of predictability between Algernon Pharmaceuticals time series from 3rd of January 2025 to 18th of January 2025 and 18th of January 2025 to 2nd of February 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Algernon Pharmaceuticals price movement. The serial correlation of 0.05 indicates that only as little as 5.0% of current Algernon Pharmaceuticals price fluctuation can be explain by its past prices.
Correlation Coefficient
0.05
Spearman Rank Test
0.61
Residual Average
0.0
Price Variance
0.0
Algernon Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Algernon Pharmaceuticals otc stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Algernon Pharmaceuticals' otc stock expected returns. We can calculate the autocorrelation of Algernon Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Algernon Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the otc stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values
Timeline
Algernon Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Algernon Pharmaceuticals otc stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Algernon Pharmaceuticals otc stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Algernon Pharmaceuticals otc stock over time.
Current vs Lagged Prices
Timeline
Algernon Pharmaceuticals Lagged Returns
When evaluating Algernon Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Algernon Pharmaceuticals otc stock have on its future price. Algernon Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Algernon Pharmaceuticals autocorrelation shows the relationship between Algernon Pharmaceuticals otc stock current value and its past values and can show if there is a momentum factor associated with investing in Algernon Pharmaceuticals.
Other Information on Investing in Algernon OTC Stock
Algernon Pharmaceuticals financial ratios help investors to determine whether Algernon OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Algernon with respect to the benefits of owning Algernon Pharmaceuticals security.